Profile
Elizabeth P.
Garcia is Senior Director of Assay Development for Primera Biosystems, Inc. She worked at Sention, Inc. She was a Research Assistant Professor of Brown University from 1996 to 2001.
Dr. Garcia received a PhD in Molecular and Cellular Biology from the University of Maryland in 1992.
Former positions of Elizabeth P. Garcia
| Companies | Position | End |
|---|---|---|
| Brown University | Corporate Officer/Principal | 2000-12-31 |
Sention, Inc.
 Sention, Inc. Pharmaceuticals: MajorHealth Technology Sention, Inc. manufactures pharmaceutical products. The company focuses on the discovery and development of drugs to treat memory impairment and other central nervous disorders. The company was founded in 1999 and is headquartered in Providence, RI | Corporate Officer/Principal | - |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Corporate Officer/Principal | - |
Training of Elizabeth P. Garcia
| University of Maryland | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Sention, Inc.
Sention, Inc. Pharmaceuticals: MajorHealth Technology Sention, Inc. manufactures pharmaceutical products. The company focuses on the discovery and development of drugs to treat memory impairment and other central nervous disorders. The company was founded in 1999 and is headquartered in Providence, RI | Health Technology |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Health Technology |
- Stock Market
- Insiders
- Elizabeth P. Garcia
